TITLE

THE EFFECT OF SUBLINGUAL HEPARIN ON LIPOPROTEIN DISTRIBUTION IN ATHEROSCLEROSIS

AUTHOR(S)
Biancani, G.
PUB. DATE
April 1961
SOURCE
Angiology;Apr1961, Vol. 12 Issue 4, p119
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the capability of sublingual heparin in restoring the distribution of lipoprotein in the body in the treatment of atherosclerosis. Cause of atherosclerosis; Importance of the clearing factor of the heparin in its capacity in treating atherosclerosis; Developments in the heparin therapy.
ACCESSION #
16432663

 

Related Articles

  • NEWER CONCEPTS IN ATHEROSCLEROSIS: SUBLINGUAL HEPARIN. Loewe, Leo; Halpern, Alfred // Angiology;Apr1961, Vol. 12 Issue 4, p117 

    Comments on the new clinical diagnosis of atherosclerosis, a formation of atheromas. Common term of the disease; Symptoms of the disease; Cause of the disease.

  • LONG-TERM DAILY OUTPATIENT HEPARIN THERAPY IN HYPERLIPEMIC AND NORMOLIPEMIC ATHEROSCLEROTIC STATES. Woldow, Asher; Goldberg, Harry; Gratz, Margaret // Angiology;Mar1970, Vol. 21 Issue 3, p180 

    1. It is confirmed that heparin given as a single dose is followed by a rebound lipemia. However, when given in multiple doses at 4-hr, intervals the rebound can be prevented and prolonged clearing accomplished. This was noted in patients confined to hospitals and reported previously. Multiple...

  • SOME HEMATOLOGIC DIFFERENCES BETWEEN THROMBOANGIITIS OBLITERANS AND ATHEROSCLEROSIS. Craven, John L.; Cotton, Roy C. // Angiology;Sep1968, Vol. 19 Issue 8, p450 

    Focuses on the hematologic differences between thromobangiitis obliterans and atherosclerosis. Concentration of heparin-precipitable fractions of fibrinogen (HPF) in the plasma of patients with thromobangiitis obliterans; Correlations between HPF and total fibrinogen; Specific nature of the two...

  • Generic Forms of Low-Molecular-Weight Heparins: Some Practical Considerations. Leong, Wendy; Hoppensteadt, Debra A. // Clinical & Applied Thrombosis/Hemostasis;Oct2003, Vol. 9 Issue 4, p293 

    This commentary briefly reviews the controversies of therapeutic and generic interchangeability, as they apply to the antithrombotic drug class called low-molecular-weight heparin (LMWH). Recommendations are prepared for the generic LMWH approval process by various regulatory bodies.

  • A NEW APPROACH IN THE TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIONS: DEFIBRINATION WITH ARVIN. Ehringer, Herbert; Dudczak, R.; Lechner, K. // Angiology;Apr1974, Vol. 25 Issue 4, p279 

    Therapeutical defibrination induced by a 10 day's arvin infusion period caused a more pronounced and more sustained decrease of blood viscosity as compared with SK. Simultaneously an increase of the rest flow of the calf and of the foot and an improvement of the efficiency of the collateral...

  • Fragmin.  // Royal Society of Medicine: Medicines;2002, p257 

    The article presents information on fragmin. The drug is a proprietary, prescription-only preparation of the dalteparin sodium, which is a low molecular weight version of heparin. It can be used for long-duration prevention of venous thrombo-embolism, particularly in orthopaedic use, It is...

  • THE EFFECT OF CONTINUED ADMINISTRATION OF SUBLINGUAL HEPARIN ON THE FAT TOLERANCE TEST. Shaftel, Herbert E.; Padernacht, Elias // Angiology;Apr1961, Vol. 12 Issue 4, p124 

    Focuses on the effect of the continued administration of sublingual heparin in treating athersclerosis on the fat tolerance test. Capabilities of heparin in treating atherosclerosis; Pros and cons in the therapeutic use of heparin; Clinical ability of heparin that triggers the difficulty in...

  • MEDICAL MANAGEMENT OF CHRONIC OCCLUSIVE ARTERIAL DISEASE. Chucker, Francis // Angiology;Nov1977, Vol. 28 Issue 11, p760 

    Most patients with arterial disease of the lower extremities have ather- osclerosis, frequently termed arteriosclerosis obliterans (ASO). Thera- peutically, both medical and/or surgical approaches are in order. Surgically, local manifestations of the disease can. be treated very effectively by...

  • A focus on risk factor management. Belch, Jill J. F.; Creager, Mark A. // Vascular Medicine;2004, Vol. 9 Issue 3, p169 

    This article reports that peripheral arterial disease (PAD) and its most common manifestation, intermittent claudication (IC), are associated with considerable morbidity and mortality. The patient with PAD has well-documented risk factors for atherosclerosis. Because of these, combined with the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics